Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors.

Autor: Kuwahara, Yoshikazu1, Mori, Miyuki2, Kitahara, Shuji3, Fukumoto, Motoi1, Ezaki, Taichi3, Mori, Shiro4, Echigo, Seishi5, Ohkubo, Yasuhito6, Fukumoto, Manabu1
Zdroj: Cancer Medicine. Apr2014, Vol. 3 Issue 2, p310-321. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje